Financhill
Back

AbCellera Biologics Quote, Financials, Valuation and Earnings

S&P Global: Private Equity Invests $36 Billion Into What?

Read More
Sell
43

ABCL
AbCellera Biologics

Last Price:
4.53
Seasonality Move:
-2.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Biden's Oil War: The Administration Is All-In on Green Energy.

Download Free Report

AbCellera Biologics Price Quote

$4.53
+0.03 (+0.67%)
(Updated: March 28, 2024 at 12:20 PM ET)

AbCellera Biologics Key Stats

Sell
43
AbCellera Biologics (ABCL) is a Sell

Day range:
$4.27 - $4.51
52-week range:
$3.87 - $8.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
34.22
P/B ratio:
1.14%

Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-40.63%
Market cap:
$1.3B
Revenue:
$38M
EPS:
$-0.52

How Much Does AbCellera Biologics Make?

Is AbCellera Biologics Growing As A Company?

  • What Is AbCellera Biologics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.57%
  • What Is AbCellera Biologics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

AbCellera Biologics Stock Price Performance

What Is AbCellera Biologics 52-Week High & Low?

AbCellera Biologics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AbCellera Biologics?

Is AbCellera Biologics Cash Flow Positive?

  • What Is ABCL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$43.9M
  • What Is AbCellera Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.4M
  • What Is AbCellera Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$221.1M

AbCellera Biologics Return On Invested Capital

  • Is Management Doing A Good Job?
    ABCL return on invested capital is -12.26%
  • What Is AbCellera Biologics Return On Assets?
    ROA measures how assets are converting to revenues and is -9.66%
  • What Is ABCL Return On Equity?
    ROE is a measure of profitability and is -12.26%

AbCellera Biologics Earnings Date & Stock Price

AbCellera Biologics Competitors

  • Who Are AbCellera Biologics's Competitors?
    Below is a list of companies who compete with AbCellera Biologics or are related in some way:
    • Acasti Pharma Inc (ACST)
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • InMed Pharmaceuticals Inc (INM)
    • Lexaria Bioscience Corp (LEXX)

AbCellera Biologics Dividend Yield

Data Unavailable

AbCellera Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -33.33%
Revenue: -57.4% -1.24%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.75
Upside from Last Price: 227.78%

Major Shareholders

  • How many ABCL shares are owned by institutional investors?
    160M ABCL shares are owned by institutional investors
  • How many ABCL shares are owned by insiders?
    4.1M ABCL shares are owned by insiders